近几年,越来越多的人出现睡眠困难,有数据统计显示,我国有1/4的人群睡眠不足6小时,近40%的人群存在夜间易醒的问题。入睡困难、睡眠不足等症状会影响人的认知表现,削弱免疫系统,导致增加患慢性疾病的概率。因此加强抗失眠药物研发举足轻重。据悉,近日康弘药业传来喜讯,公司自主研发的化药1类创新药KHN707片已获得国家药品监督管理局下发的药物临床试验批准通知书,同意该药品开展用于失眠症的临床试验。该...
Source Link近几年,越来越多的人出现睡眠困难,有数据统计显示,我国有1/4的人群睡眠不足6小时,近40%的人群存在夜间易醒的问题。入睡困难、睡眠不足等症状会影响人的认知表现,削弱免疫系统,导致增加患慢性疾病的概率。因此加强抗失眠药物研发举足轻重。据悉,近日康弘药业传来喜讯,公司自主研发的化药1类创新药KHN707片已获得国家药品监督管理局下发的药物临床试验批准通知书,同意该药品开展用于失眠症的临床试验。该...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.